Cidara Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2015 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cidara Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2015 to Q3 2024.
  • Cidara Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 7.05M shares, a 92.2% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 7.05M -83.4M -92.2% Nov 4, 2024 10-Q 2024-11-07
Q2 2024 7.04M -83.2M -92.2% Aug 8, 2024 10-Q 2024-08-13
Q1 2024 91.2M +2.23M +2.5% Apr 12, 2024 10-K 2024-04-22
Q3 2023 90.4M +18.8M +26.3% Oct 31, 2023 10-Q 2023-11-02
Q2 2023 90.3M +20.2M +28.8% Jul 31, 2023 10-Q 2023-08-03
Q1 2023 89M +20M +28.9% Mar 16, 2023 10-K 2023-03-23
Q3 2022 71.6M +4.93M +7.4% Oct 31, 2022 10-Q 2022-11-03
Q2 2022 70.1M +20.6M +41.5% Jul 29, 2022 10-Q 2022-08-09
Q1 2022 69M +20.8M +43% Apr 29, 2022 10-Q 2022-05-11
Q3 2021 66.7M +22.7M +51.8% Oct 29, 2021 10-Q 2021-11-10
Q2 2021 49.5M +6.55M +15.2% Jul 30, 2021 10-Q 2021-08-12
Q1 2021 48.3M +7.54M +18.5% Apr 30, 2021 10-Q 2021-05-13
Q3 2020 43.9M +10.9M +33% Oct 31, 2020 10-Q 2020-11-05
Q2 2020 43M +16.2M +60.5% Jul 31, 2020 10-Q 2020-08-13
Q1 2020 40.7M +14.1M +52.9% Apr 30, 2020 10-Q 2020-05-13
Q3 2019 33M +5.29M +19.1% Oct 31, 2019 10-Q 2019-11-08
Q2 2019 26.8M -912K -3.29% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 26.6M +5.25M +24.5% Apr 30, 2019 10-Q 2019-05-09
Q3 2018 27.8M +7.51M +37.1% Oct 31, 2018 10-Q 2018-11-08
Q2 2018 27.7M +10.8M +64.1% Jul 31, 2018 10-Q 2018-08-09
Q1 2018 21.4M +4.59M +27.3% Apr 30, 2018 10-Q 2018-05-10
Q3 2017 20.2M +3.56M +21.4% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 16.9M +2.96M +21.3% Jul 31, 2017 10-Q 2017-08-09
Q1 2017 16.8M +2.95M +21.3% Apr 30, 2017 10-Q 2017-05-10
Q3 2016 16.7M +2.95M +21.5% Oct 31, 2016 10-Q 2016-11-10
Q2 2016 13.9M +232K +1.7% Jul 31, 2016 10-Q 2016-08-11
Q1 2016 13.9M Apr 30, 2016 10-Q 2016-05-12
Q3 2015 13.7M Nov 10, 2015 10-Q 2015-11-16
Q2 2015 13.7M Aug 10, 2015 10-Q 2015-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.